Answers are grounded in this paper and cite their sources.
TTA-A2 can be used as an adjuvant to reduce chemoresistance in cancer cells as well as to enhance the anticancer effect of the standard anticancer drug PTX. Being a potent TTCC inhibitor, TTA-A2 may also enhance the anticancer effects of other anticancer drugs.
No takes yet. Share an insight, caveat, or question.
Kumari et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: